Health
Partnership to Explore Drug Delivery Approaches Labmate Online – Labmate Online
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential…
Reagents and therapeutics developer Aptamer Group has extended its existing collaboration with global biopharmaceutical company AstraZeneca to evaluate potential use of its Optimer-based strategies to target renal cells and the feasibility of developing next-generation drug delivery conjugates.
Based on oligonucleotide molecules optimers can bind specifically to a target molecule to act as an antibody alternative. Their ability to fold into distinct secondary or tertiary structures gives them high…
-
Noosa News22 hours agoBrisbane’s Triffid forces redesign of $1.5 billion tower project
-
General21 hours agoSussan Ley’s office says Bridget McKenzie made false claims about cabinet solidarity
-
General18 hours agoIsraeli forces open fire towards diplomatic delegation touring Jenin in the northern West Bank
-
General11 hours agoCharlotte McConaghy calls for climate change action in new novel Wild Dark Shore